CHUN-WEN CHENGYU-FAN LIU2026-10-162026-10-162012-12-01Pure ID: 14908117Pure UUID: 40839112-418b-4c5d-85cc-a1984790d68f10.1245/s10434-012-2541-xhttps://www.scopus.com/pages/publications/84876468473https://scholars.csmu.edu.tw/handle/123456789/26600Background. To investigate markers for predicting breast cancer progression, we performed a candidate gene-based study that assessed expression change of three genes, cyclin D1, b-catenin, and metastasis-associated protein-1 (MTA1), involving in aggressive phenotypes of cancerous cells, namely hyperproliferation, epithelial-mesenchymal transition, and global transcriptional regulation. Methods. Specimens were from 150 enrolled female patients, with invasive ductal carcinoma, followed up for more than 10 years. mRNA expression of cyclin D1, b-catenin, and MTA1 in cancerous and noncancerous cells microdissected from the primary tumor site was determined by quantitative real-time PCR. The relationship between mRNA expression levels of the genes and clini-copathologic features was assessed by statistical analysis. Disease-free and overall survival (DFS and OS) were analyzed by Kaplan-Meier analysis with log-rank test and a multivariate Cox regression model. Results. Cyclin D1 was shown to be overexpressed in latestage breast cancer (stage III/IV). Breast cancer with lymph node metastasis (LNM) showed significantly higher frequency of overexpressed cyclin D1, b-catenin, and MTA1 (P < 0.05). Patients carrying greater numbers of overex-pressed genes had joint effects on increased risk in tumors of advanced stages (Ptrend = 0.03) and LNM (Ptrend < 0.01). In the LNM-negative group, patients whose tumors with greater number of cyclin D1, b-catenin, and MTA1 overex-pressions were associated with poorer clinical outcomes, with hazard ratio of 14.79 for OS (P = 0.015) and 7.54 for DFS (P = 0.015) using multivariate Cox regression analysis during the 10-year follow-up. Conclusions. Higher expression of cyclin D1, b-catenin, and MTA1 mRNAs in breast cancers may prove effective in predicting unfavorable outcomes of breast cancer.11enPrognostic significance of cyclin D1, b-catenin, and MTA1 in patients with invasive ductal carcinoma of the breastjournal article